University of Groningen Individualized Prediction of Transition to Psychosis in 1 , 676 Individuals at Clinical High Risk

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models.

  2019cited by this paper
• Real World Implementation of a Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk of Psychosis in Clinical Routine: Study Protocol

  2019cited by this paper
• Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis

  2018cited by this paper
• Scale for the Assessment of Positive Symptoms

  2018influential reference
• The Science of Prognosis in Psychiatry: A Review

  2018influential reference
• Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis

  2018cited by this paper
• What causes psychosis? An umbrella review of risk and protective factors

  2018cited by this paper
• Transdiagnostic Risk Calculator for the Automatic Detection of Individuals at Risk and the Prediction of Psychosis: Second Replication in an Independent National Health Service Trust

  2018cited by this paper
• Development and Validation of a Clinically Based Risk Calculator for the Transdiagnostic Prediction of Psychosis

  2017cited by this paper
• Correlations between self‐rating and observer‐rating of psychopathology in at‐risk mental state and first‐episode psychosis patients: influence of disease stage and gender

  2017influential reference
• Deconstructing Vulnerability for Psychosis: Meta-Analysis of Environmental Risk Factors for Psychosis in Subjects at Ultra High-Risk

  2017cited by this paper
• The Clinical High-Risk State for Psychosis (CHR-P), Version II

  2017cited by this paper
• Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it

  2017cited by this paper
• Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders

  2017cited by this paper
• Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting

  2017cited by this paper
• Why transition risk to psychosis is not declining at the OASIS ultra high risk service: The hidden role of stable pretest risk enrichment.

  2017cited by this paper
• The Clinic for Assessment of Youth at Risk (CAYR): 10 years of service delivery and research targeting the prevention of psychosis in Montreal, Canada

  2017cited by this paper
• Personalized Prediction of Psychosis: External Validation of the NAPLS-2 Psychosis Risk Calculator With the EDIPPP Project.

  2016cited by this paper
• An Individualized Risk Calculator for Research in Prodromal Psychosis.

  2016cited by this paper
• Improving Prognostic Accuracy in Subjects at Clinical High Risk for Psychosis: Systematic Review of Predictive Models and Meta-analytical Sequential Testing Simulation

  2016cited by this paper
• Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.

  2016cited by this paper
• Cross-trial prediction of treatment outcome in depression: a machine learning approach.

  2016cited by this paper
• Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk.

  2016cited by this paper
• External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges

  2016cited by this paper
• The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review

  2015cited by this paper
• Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement.

  2015cited by this paper
• Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?

  2015cited by this paper
• Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD)

  2015cited by this paper
• The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

  2015cited by this paper
• Twelve-month psychosis-predictive value of the ultra-high risk criteria in children and adolescents.

  2015influential reference
• Breast Cancer Risks and Risk Prediction Models

  2015cited by this paper
• Individual Participant Data (IPD) Meta-analyses of Diagnostic and Prognostic Modeling Studies: Guidance on Their Use

  2015cited by this paper
• At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction

  2015cited by this paper
• PORT (Programme of Recognition and Therapy): the first Polish recognition and treatment programme for patients with an at‐risk mental state

  2015influential reference
• Disorder, not just state of risk: Meta-analysis of functioning and quality of life in people at high risk of psychosis

  2015cited by this paper
• Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms.

  2014influential reference
• The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses

  2014influential reference
• Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.

  2014cited by this paper
• Psychosis prediction: stratification of risk estimation with information-processing and premorbid functioning variables.

  2014cited by this paper
• Converting positive and negative symptom scores between PANSS and SAPS/SANS.

  2014cited by this paper
• Developing and validating risk prediction models in an individual participant data meta-analysis

  2014cited by this paper
• A naturalistic longitudinal study of at-risk mental state with a 2.4 year follow-up at a specialized clinic setting in Japan.

  2014influential reference
• Neurocognitive and Clinical Predictors of Long-Term Outcome in Adolescents at Ultra-High Risk for Psychosis: A 6-Year Follow-Up

  2014influential reference
• The prevention and handling of the missing data

  2013cited by this paper
• Outreach and support in South London (OASIS), 2001–2011: Ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis

  2013influential reference
• Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups.

  2013cited by this paper
• Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.

  2013influential reference
• Prognostic models for stable coronary artery disease based on electronic health record cohort of 102 023 patients

  2013cited by this paper
• A multimodal approach to investigate biomarkers for psychosis in a clinical setting: the integrative neuroimaging studies in schizophrenia targeting for early intervention and prevention (IN-STEP) project.

  2013influential reference
• Predicting Psychosis: Meta-analysis of Transition Outcomes in Individuals at High Clinical Risk

  2013cited by this paper
• Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts.

  2013cited by this paper
• A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta‐analysis

  2013cited by this paper
• Cognitive behavioral therapy for subjects at ultrahigh risk for developing psychosis: a randomized controlled clinical trial.

  2012influential reference
• Risk prediction models: II. External validation, model updating, and impact assessment

  2012cited by this paper
• Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis.

  2012cited by this paper
• Negative symptoms in individuals at clinical high risk of psychosis.

  2012cited by this paper
• A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis.

  2011influential reference
• Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures

  2010cited by this paper
• Prognosis and prognostic research: what, why, and how?

  2009cited by this paper
• Prescription of antipsychotic medication to patients at ultra high risk of developing psychosis

  2009cited by this paper
• Imputing missing covariate values for the Cox model

  2009cited by this paper
• Early detection of psychosis – Establishing a service for persons at risk

  2009cited by this paper
• [The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity].

  2008influential reference
• Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

  2007influential reference
• The Basel early‐detection‐of‐psychosis (FEPSY)‐study – design and preliminary results

  2007cited by this paper
• Age of onset of mental disorders: a review of recent literature

  2007cited by this paper
• Mapping the Onset of Psychosis: The Comprehensive Assessment of At-Risk Mental States

  2005influential reference
• Consensus Statement

  2004cited by this paper
• Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

  2003influential reference
• Loss to Follow-Up in Cohort Studies: How Much is Too Much?

  2003cited by this paper
• The Lognormal Distribution as a Model for Survival Time in Cancer, With an Emphasis on Prognostic Factors

  2001cited by this paper
• Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis

  2001cited by this paper
• Symptom dimensions in recent-onset schizophrenia and mania: a principal components analysis of the 24-item Brief Psychiatric Rating Scale.

  2000influential reference
• Global assessment of functioning. A modified scale.

  1995cited by this paper
• Revising axis V for DSM-IV: a review of measures of social functioning.

  1992cited by this paper
• Scale for the Assessment of Negative Symptoms (SANS)*

  1989influential reference
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987influential reference
• The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome.

  1984influential reference
• A children's global assessment scale (CGAS).

  1983cited by this paper
• Regression Diagnostics: Identifying Influential Data and Sources of Collinearity

  1980cited by this paper
• Clinician's judgments of mental health.

  1962influential reference

• No citing papers are available for this paper.